Search Orphan Drug Designations and Approvals
-
Generic Name: | 1-(4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide |
---|---|
Date Designated: | 07/08/2015 |
Orphan Designation: | Treatment of multiple myeloma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 07/07/2017 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Cleave Biosciences, Inc. 866 Malcolm Road Suite 100 Burlingame, California 94010 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-